Group problem management plus (gPM+) in the treatment of common mental disorders in Syrian refugees in a Jordanian camp: study protocol for a randomized controlled trial.
Behavioural intervention
Controlled trial
Mental health
Psychosocial intervention
Refugees
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
26 Mar 2020
26 Mar 2020
Historique:
received:
06
02
2020
accepted:
05
03
2020
entrez:
29
3
2020
pubmed:
29
3
2020
medline:
8
8
2020
Statut:
epublish
Résumé
Accessing quality mental health care poses significant challenges for persons affected by adversity, especially in low- and middle-income countries where resources are scarce. To mitigate this, the World Health Organization has developed group problem management plus (gPM+), a low-intensity psychological intervention for adults experiencing psychological distress. gPM+ is a group-based intervention consisting of five-sessions, and can be delivered by non-specialist providers. This paper outlines the study protocol for a trial of gPM+ in Jordan. We will conduct a single-blind, two-arm, randomized controlled trial in a Syrian refugee camp in Jordan. We aim to enrol 480 adults into the trial. Participants will be eligible for the trial if they screen positive for levels of psychological distress. Following screening, those eligible will be randomly assigned to receive the gPM+ intervention or enhanced treatment as usual. The primary outcome is reduction in levels of psychological distress at 3-months post-treatment. Secondary outcomes include anxiety, depression, prodromal psychotic symptoms, posttraumatic stress disorder, prolonged grief, daily functioning, economic effectiveness, and change in parenting behaviour. Secondary outcomes also include the reduction in psychological distress of the participant's child. The trial aims to deliver a template for affordable and scalable psychosocial interventions that can readily be implemented in refugee settings, and that can benefit both the participant and their child. Australian New Zealand Clinical Trials Registry, ACTRN12619001386123. Registered prospectively on 10/10/2019.
Sections du résumé
BACKGROUND
BACKGROUND
Accessing quality mental health care poses significant challenges for persons affected by adversity, especially in low- and middle-income countries where resources are scarce. To mitigate this, the World Health Organization has developed group problem management plus (gPM+), a low-intensity psychological intervention for adults experiencing psychological distress. gPM+ is a group-based intervention consisting of five-sessions, and can be delivered by non-specialist providers. This paper outlines the study protocol for a trial of gPM+ in Jordan.
METHODS
METHODS
We will conduct a single-blind, two-arm, randomized controlled trial in a Syrian refugee camp in Jordan. We aim to enrol 480 adults into the trial. Participants will be eligible for the trial if they screen positive for levels of psychological distress. Following screening, those eligible will be randomly assigned to receive the gPM+ intervention or enhanced treatment as usual. The primary outcome is reduction in levels of psychological distress at 3-months post-treatment. Secondary outcomes include anxiety, depression, prodromal psychotic symptoms, posttraumatic stress disorder, prolonged grief, daily functioning, economic effectiveness, and change in parenting behaviour. Secondary outcomes also include the reduction in psychological distress of the participant's child.
DISCUSSION
CONCLUSIONS
The trial aims to deliver a template for affordable and scalable psychosocial interventions that can readily be implemented in refugee settings, and that can benefit both the participant and their child.
TRIAL REGISTRATION
BACKGROUND
Australian New Zealand Clinical Trials Registry, ACTRN12619001386123. Registered prospectively on 10/10/2019.
Identifiants
pubmed: 32216762
doi: 10.1186/s12889-020-08463-5
pii: 10.1186/s12889-020-08463-5
pmc: PMC7098148
doi:
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
390Subventions
Organisme : National Health and Medical Research Council
ID : 1142605
Organisme : Horizon 2020
ID : 733337
Références
PLoS One. 2011;6(12):e27378
pubmed: 22194783
Harv Rev Psychiatry. 2012 Jan-Feb;20(1):25-36
pubmed: 22335180
Arch Gen Psychiatry. 2003 Feb;60(2):184-9
pubmed: 12578436
Lancet Public Health. 2018 May;3(5):e249-e258
pubmed: 29731158
PLoS Med. 2017 Aug 15;14(8):e1002371
pubmed: 28809935
PLoS Med. 2009 Aug;6(8):e1000121
pubmed: 19652695
Assessment. 2004 Dec;11(4):330-41
pubmed: 15486169
World Psychiatry. 2015 Oct;14(3):354-7
pubmed: 26407793
Scand J Public Health. 2019 Dec 8;:1403494819882137
pubmed: 31814514
Lancet. 2005 Apr 9-15;365(9467):1309-14
pubmed: 15823380
Epidemiol Psychiatr Sci. 2016 Apr;25(2):129-41
pubmed: 26829998
Child Abuse Negl. 1993 Nov-Dec;17(6):843-54
pubmed: 8287295
JAMA. 2007 Aug 1;298(5):519-27
pubmed: 17666672
JAMA. 2011 Aug 3;306(5):503-12
pubmed: 21813428
J Rural Health. 2018 Dec;34(1):48-62
pubmed: 28084667
Lancet. 2019 Apr 27;393(10182):1733-1744
pubmed: 30948286
JAMA. 2016 Dec 27;316(24):2609-2617
pubmed: 27837602
Br J Psychiatry. 1997 Apr;170:351-7
pubmed: 9246254
Annu Rev Clin Psychol. 2017 May 8;13:149-181
pubmed: 28482687
Schizophr Res. 2011 Jun;129(1):42-6
pubmed: 21511440
Br J Psychiatry Suppl. 2000;(39):s28-33
pubmed: 10945075
N Engl J Med. 2013 Jun 6;368(23):2182-91
pubmed: 23738545
Arch Pediatr Adolesc Med. 1999 Mar;153(3):254-60
pubmed: 10086402
PLoS One. 2015 Apr 29;10(4):e0125178
pubmed: 25923209
J Consult Clin Psychol. 2008 Aug;76(4):686-94
pubmed: 18665696
Psychol Assess. 2016 May;28(5):613-625
pubmed: 26348028
Eur Psychiatry. 2013 Oct;28(8):514-20
pubmed: 22986125
Ann Intern Med. 2013 Feb 5;158(3):200-7
pubmed: 23295957
Clin Psychol Rev. 2011 Apr;31(3):399-417
pubmed: 21112681
PLoS Med. 2014 Nov 11;11(11):e1001757
pubmed: 25386945
Aust N Z J Psychiatry. 2011 Apr;45(4):308-16
pubmed: 21332432
Behav Sci. 1974 Jan;19(1):1-15
pubmed: 4808738
JAMA. 2009 Aug 5;302(5):537-49
pubmed: 19654388
Depress Anxiety. 2017 Aug;34(8):679-691
pubmed: 28419625